Abstract
Malignant tumors of the salivary glands account for 3–5 % of all head and neck cancers. Adenocystic carcinomas are malignant neoplasms that most often arise from large and small salivary glands. The disease is characterized by a progressive course with local and distant relapses.The article presents a clinical case of successful treatment with lenvatinib in suboptimal doses of adenocystic carcinoma of the parotid salivary gland.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
